Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models.

MLA

Kim, Peter S., et al. “Modeling Imatinib-Treated Chronic Myelogenous Leukemia: Reducing the Complexity of Agent-Based Models.” Bulletin of Mathematical Biology, vol. 70, no. 3, Apr. 2008, pp. 728–44. EBSCOhost, https://doi.org/10.1007/s11538-007-9276-z.

APA

Kim, P. S., Lee, P. P., & Levy, D. (2008). Modeling imatinib-treated chronic myelogenous leukemia: reducing the complexity of agent-based models. Bulletin of Mathematical Biology, 70(3), 728–744. https://doi.org/10.1007/s11538-007-9276-z

Chicago

Kim, Peter S, Peter P Lee, and Doron Levy. 2008. “Modeling Imatinib-Treated Chronic Myelogenous Leukemia: Reducing the Complexity of Agent-Based Models.” Bulletin of Mathematical Biology 70 (3): 728–44. doi:10.1007/s11538-007-9276-z.